Oxurion NV TG4.F Stock
Oxurion NV Price Chart
Oxurion NV TG4.F Financial and Trading Overview
| Oxurion NV stock price | 0.0001 EUR |
| Previous Close | 0.0006 EUR |
| Open | 0.0006 EUR |
| Bid | 0.0001 EUR x 250000 |
| Ask | 0.0052 EUR x 250000 |
| Day's Range | 0.0006 - 0.0006 EUR |
| 52 Week Range | 0.0002 - 0.2 EUR |
| Volume | 100K EUR |
| Avg. Volume | 1.59K EUR |
| Market Cap | 3.47M EUR |
| Beta (5Y Monthly) | 0.345345 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TG4.F Valuation Measures
| Enterprise Value | 4.78M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.828743 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 8.027 |
| Enterprise Value/EBITDA | -0.218 |
Trading Information
Oxurion NV Stock Price History
| Beta (5Y Monthly) | 0.345345 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.2 EUR |
| 52 Week Low | 0.0002 EUR |
| 50-Day Moving Average | 0.0006 EUR |
| 200-Day Moving Average | 0.005831 EUR |
TG4.F Share Statistics
| Avg. Volume (3 month) | 1.59K EUR |
| Avg. Daily Volume (10-Days) | 10K EUR |
| Shares Outstanding | 2.67B |
| Float | 582.45M |
| Short Ratio | N/A |
| % Held by Insiders | 3.31% |
| % Held by Institutions | 2.22% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3688.40% |
| Gross Margin | 13.78% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -88.86% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 595K EUR |
| Revenue Per Share (ttm) | 0.007 EUR |
| Quarterly Revenue Growth (yoy) | -57.89% |
| Gross Profit (ttm) | N/A |
| EBITDA | -21883000 EUR |
| Net Income Avi to Common (ttm) | -31685000 EUR |
| Diluted EPS (ttm) | -0.37 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.59M EUR |
| Total Cash Per Share (mrq) | 0.006 EUR |
| Total Debt (mrq) | 8.02M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.575 |
| Book Value Per Share (mrq) | -0.011 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19379000 EUR |
| Levered Free Cash Flow (ttm) | -12315375 EUR |
Profile of Oxurion NV
| Country | Germany |
| State | N/A |
| City | Leuven |
| Address | Gaston Geenslaan 1 |
| ZIP | 3001 |
| Phone | 32 1 675 13 10 |
| Website | https://www.oxurion.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 27 |
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist, which is in Phase II clinical trials for the treatment of DME. Oxurion NV has collaboration agreements with Bicycle Therapeutics and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
Q&A For Oxurion NV Stock
What is a current TG4.F stock price?
Oxurion NV TG4.F stock price today per share is 0.0001 EUR.
How to purchase Oxurion NV stock?
You can buy TG4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oxurion NV?
The stock symbol or ticker of Oxurion NV is TG4.F.
Which industry does the Oxurion NV company belong to?
The Oxurion NV industry is Biotechnology.
How many shares does Oxurion NV have in circulation?
The max supply of Oxurion NV shares is 9.01B.
What is Oxurion NV Price to Earnings Ratio (PE Ratio)?
Oxurion NV PE Ratio is now.
What was Oxurion NV earnings per share over the trailing 12 months (TTM)?
Oxurion NV EPS is -0.07 EUR over the trailing 12 months.
Which sector does the Oxurion NV company belong to?
The Oxurion NV sector is Healthcare.